tirzepatide cause high blood pressure GLP-1 medications are rewriting the rules of cardiovascular medicine. A landmark meta-analysis of 99,599 patients found: ✓ 20% reduction in major cardiovascular events ✓ 12% reduction in all-cause death ✓ 15% reduction Tirzepatide Blood Pressure Reduction: Clinical

5 Conclusion This study systematically analyzed data from the FAERS database, covering from Q1 2004 to Q2 2024, to investigate reports of cholecystitis and cholelithiasis in which GLP-1 RAs were identified as the primary suspect drug

doi: 10.1016/j.bmc.2014.05.008 89 RosensonRSGaudetDBallantyneCMBaumSJBergeronJKershawEEet al

Safe, Comfortable Environment Your comfort and safety are our top priorities, from consultation through every step of care

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context on your individual predispositions in key GLP-1 signaling and metabolic pathways

7,21,24,26,32,33 The distribution of variables between cases and controls, including marital status, education, occupation, duration of type 2 diabetes mellitus (T2DM), and the number of comorbidities, does not significantly impact hypoglycemic risk, as determined by chi-square analysis

The clinical evidence behind these medications is substantial